-
Mashup Score: 8Join me! | A Discussion of the Rapidly Evolving Landscape in Endometrial Cancer: Addressing Clinical Changes, Challenges, and Disparities - 25 day(s) ago
Live webinar with experts covering recent advances and new clinical data in the rapidly evolving landscape for endometrial cancer, addressing clinical changes, challenges, and health disparities.
Source: clinicaloptions.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The survival benefit with dostarlimab/chemotherapy was deemed unprecedented in patients with microsatellite instability high primary advanced or recurrent endometrial cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
The combination of dostarlimab plus carboplatin/paclitaxel demonstrated a 31% improvement in OS vs placebo/chemotherapy in patients with primary advanced or recurrent endometrial cancer, irrespective of MSI status. #SGOMtg | @SGO_org @matthewapowell https://t.co/EqFRwjKt76
-
-
Mashup Score: 4Pembrolizumab Combo Yields Survival Benefit in Endometrial Cancer - 1 month(s) ago
Results from the KEYNOTE-868 trial showed a favorable benefit of pembrolizumab plus chemotherapy across endometrial cancer subgroups.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
“These findings are supportive of the addition of pembrolizumab to chemotherapy as a first-line treatment for patients with advanced or recurrent endometrial cancer, regardless of MMR status,” said Ramez N. Eskander, MD. #SGOMtg | @SGO_org @rne_md https://t.co/EpPBnojuUj
-
-
Mashup Score: 2
Dostarlimab plus chemotherapy appears to yield favorable overall survival in patients with mismatch repair proficient endometrial cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
Combining dostarlimab with chemotherapy produced a clinically meaningful and statistically significant improvement in OS among patients with primary advanced or recurrent endometrial cancer, especially those with dMMR disease. #SGOMtg | @SGO_org https://t.co/4wUu5bGLCz https://t.co/FV5JHtCmcL
-
-
Mashup Score: 3
Latest analysis of the results from the DUO-E Phase III trial showed IMFINZI ® (durvalumab) plus platinum-based chemotherapy followed by IMFINZI plus LYNPARZA ® (olaparib) (LYNPARZA and IMFINZI arm) demonstrated an improvement in multiple key secondary efficacy endpoints, particularly in patients with mismatch repair proficient (pMMR) advanced or recurrent endometrial cancer compared to chemotherapy alone. These results will be presented today in a late-breaking session at the 2024 Society of Gynecologic
Source: www.astrazeneca-us.comCategories: General Medicine News, PayerTweet-
Today, we presented the latest analysis of the results from the DUO-E Phase III trial in advanced or recurrent endometrial cancer at @SGO_org 2024 Conference. Learn more about these data from the #SGOMtg https://t.co/eeYZtZ8r9z. https://t.co/veWN0QIrKK
-
-
Mashup Score: 312024 SGO Winter Meeting - 3 month(s) ago
Explore this photo album by Society of Gynecologic Oncology/Foundation for Wom on Flickr!
Source: www.flickr.comCategories: General Medicine News, Onc News and JournalsTweet-
The SGO Winter Meeting is underway, starting bright and early this morning with a great opening ceremony and meaningful educational sessions to a record-breaking audience of over 460 participants. Follow along in the #SGOMtg Flickr folder: https://t.co/YuuyATuNrL https://t.co/PaaYTidZws
-
-
Mashup Score: 312024 SGO Winter Meeting - 3 month(s) ago
Explore this photo album by Society of Gynecologic Oncology/Foundation for Wom on Flickr!
Source: www.flickr.comCategories: General Medicine News, Onc News and JournalsTweet-
The SGO Winter Meeting is underway, starting bright and early this morning with a great opening ceremony and meaningful educational sessions to a record-breaking audience of over 460 participants. Follow along in the #SGOMtg Flickr folder: https://t.co/YuuyATuNrL https://t.co/PaaYTidZws
-
-
Mashup Score: 302024 SGO Winter Meeting - 3 month(s) ago
Explore this photo album by Society of Gynecologic Oncology/Foundation for Wom on Flickr!
Source: www.flickr.comCategories: General Medicine News, Onc News and JournalsTweet-
The SGO Winter Meeting is underway, starting bright and early this morning with a great opening ceremony and meaningful educational sessions to a record-breaking audience of over 460 participants. Follow along in the #SGOMtg Flickr folder: https://t.co/YuuyATuNrL https://t.co/PaaYTidZws
-
-
Mashup Score: 4SGO Allied Health Professionals Meeting - 8 month(s) ago
Explore this photo album by Society of Gynecologic Oncology on Flickr!
Source: www.flickr.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The SGO 2023 Allied Health Professionals Meeting is wrapping up! What a phenomenal weekend it has been, filled with inspiring talks, valuable insights, and meaningful connections. Thank you to everyone here who made the event possible. See photos https://t.co/cydLyVin6v. #SGOMtg https://t.co/4n8zAi3ea4
-
-
Mashup Score: 0Registration | Society of Gynecologic Oncology - 8 month(s) ago
This year’s conference will be in-person only. No virtual option will be available for this conference. On or Before July 28, 2023 After July 28, 2023 To save money on registration, apply for SGO membership by contacting membership@sgo.org. REGISTRATION CANCE LLATION POLICY: Cancellation requests submitted to meetings@sgo.org on or before July 28, 2023, will receive a full refund less a $100 USD administration fee. After July 28, 2023, there will be no refunds granted for any cancellations or for
Source: www.sgo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The 2023 #SGOAlliedHealth Professionals Meeting kicks off this Friday in Phoenix, AZ! Want to join us? Register now: https://t.co/waDRswadbO #SGOMtg https://t.co/J7CtGBKmoV
-
The SGO 2024 Annual Meeting on Women's Cancer might be over, but the learning doesn't stop! This ISS will cover the rapidly evolving landscape in the management of endometrial cancer. #SGOMtg Save the date for one of the two upcoming live webinars: https://t.co/qwvk5Bb8Rm https://t.co/3ZRfPc3Bau